48,466
edits
Difference between revisions of "Hepatocyte nuclear factor-1beta"
Jump to navigation
Jump to search
Hepatocyte nuclear factor-1beta (view source)
Revision as of 16:05, 3 August 2021
, 16:05, 3 August 2021+more
(+more) |
|||
| Line 8: | Line 8: | ||
Note: | Note: | ||
*CA-125, RCCma, and CD10 can help distinguish ''clear cell renal cell carcinoma'' and ''Müllerian clear cell tumours''.<ref name=pmid25279712>{{cite journal |authors=Mentrikoski MJ, Wendroth SM, Wick MR |title=Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin |journal=Appl Immunohistochem Mol Morphol |volume=22 |issue=9 |pages=635–41 |date=October 2014 |pmid=25279712 |doi=10.1097/PAI.0000000000000004 |url=}}</ref> | *CA-125, RCCma, and CD10 can help distinguish ''clear cell renal cell carcinoma'' and ''Müllerian clear cell tumours''.<ref name=pmid25279712>{{cite journal |authors=Mentrikoski MJ, Wendroth SM, Wick MR |title=Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin |journal=Appl Immunohistochem Mol Morphol |volume=22 |issue=9 |pages=635–41 |date=October 2014 |pmid=25279712 |doi=10.1097/PAI.0000000000000004 |url=}}</ref> | ||
===Occasionally positive=== | |||
*Lung adenocarcinoma.<ref name=pmid30065837/> | |||
*Prostate adenocarcinoma.<ref name=pmid30065837/> | |||
*Gastroesophageal adenocarcinoma.<ref name=pmid30065837/> | |||
==Negative== | |||
*Hepatocellular carcinoma.<ref name=pmid30065837/> | |||
*Colorecal adenocarcinoma.<ref name=pmid30065837/> | |||
*Breast adenocarcinoma.<ref name=pmid30065837/> | |||
*Lung squamous cell carcioma.<ref name=pmid30065837/> | |||
==Negative== | ==Negative== | ||